n. a member of a group of centrally acting muscle relaxants used as an adjunctive agent in the management of musculoskeletal pain. Because methocarbamol does not directly reduce skeletal muscle tension, its therapeutic action is thought to be due to its sedative or CNS depressant properties. It is available in tablet and injectable forms. U.S. trade name: Robaxin.